Results 211 to 220 of about 429,846 (301)

Association Between the WHO Package of Essential Non-Communicable Disease Interventions and Clinical Outcomes Among Patients With Hypertension and Diabetes in Palestine: A Comparative Cross-Sectional Study. [PDF]

Health Sci Rep
Mesk Z, Qtait M, Harahsha E, Haltam AA, Ashour S, Khallaf Y, TiTI H.   +6 more
europepmc   +1 more source

Determining the Minimal Clinically Important Difference of the 40‐Item Smell Identification Test in People With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are highly prevalent among people with cystic fibrosis (PwCF) and negatively impact quality of life. The 40‐item Smell Identification Test (SIT) is widely used to assess psychophysical olfaction, but a CF‐specific minimal clinically important difference (MCID) has not been ...
Eugene Oh, Jessa E. Miller, Michelle J. Lee, Anna Zemke, David Baraghoshi, Matthew J. Strand, Jeremiah A. Alt, Todd E. Bodner, Michael Chang, Naweed I. Chowdhury, Patricia H. Eshaghian, Anne E. Getz, Jennifer L. Goralski, David A. Gudis, Peter H. Hwang, Ashoke Khanwalkar, Adam J. Kimple, Jivianne T. Lee, Douglas A. Li, Jess C. Mace, Jayakar V. Nayak, Jonathan B. Overdevest, Zara Patel, Daniella K. Safatian, Rodney J. Schlosser, Brent Senior, Amanda L. Stapleton, Timothy L. Smith, Zachary M. Soler, Jeffrey D. Suh, Grant A. Turner, Marilene B. Wang, Milene T. Saavedra, Jennifer L. Taylor‐Cousar, Daniel M. Beswick   +34 more
wiley   +1 more source

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. [PDF]

J Immunother Cancer
Sato Y, Kodama T, Maesaka K, Kai M, Murai K, Tahata Y, Saito Y, Nakabori T, Ohkawa K, Tanaka S, Sakamori R, Miyazaki M, Furuta K, Ishida H, Matsumoto K, Tawara S, Yakushijin T, Nozaki Y, Hosui A, Nishio A, Tatsumi N, Kakita N, Yoo C, Fukai M, Taketomi A, Hikita H, Tatsumi T, Takehara T.   +27 more
europepmc   +1 more source

Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP.
Nicholas J. Campion, Peta‐Lee Sacks, Lu Hui Png, Ruoxin Hua, Rhea Darbari Kaul, Raquel Alvarado, Christine Choy, Raymond Sacks, Peter Earls, Raewyn G. Campbell, Larry Kalish, Richard J. Harvey   +11 more
wiley   +1 more source

Correction: Group B Streptococcus maternal colonization and neonatal sepsis in Belgium between 2012 and 2021: a description of the epidemiological situation and identification of risk factors. [PDF]

BMC Pregnancy Childbirth
Bognár Z, Leroy C, Leeuw VV, Goemaes R, Melin P, Meex C, Sacheli R, Camfferman F, Litzroth A, De Keersmaeker F, Cornelissen L.   +10 more
europepmc   +1 more source

Multivariable adaptive control [PDF]

, 2006
openaire   +1 more source

Blood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory–Validation Study

Annals of Neurology, EarlyView.
Objective Lactate is increasingly recognized as an energy substrate, but its relevance to amyotrophic lateral sclerosis (ALS) remains unclear. We examined whether blood lactate is associated with survival and weight loss in ALS. Methods This retrospective study included an Australian exploratory cohort and a Japanese validation cohort with clinical ...
Ryutaro Nakamura, Frederik J. Steyn, Shuhei Kobashi, Nobuhiro Ogawa, Akihiro Kitamura, Isamu Yamakawa, Robert D. Henderson, Shyuan T. Ngo, Makoto Urushitani   +8 more
wiley   +1 more source

Improving Combustion Efficiency by Multivariable Analysis and Control

Measurement + Control, 1985
Ronald H Sunderland
doaj   +1 more source

Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes. [PDF]

Ther Adv Neurol Disord
Ziccardi S, Marastoni D, Biasi P, Tamanti A, Pizzini FB, Calderone M, Camera V, Bertolazzo M, Daldosso A, Milocco B, Magliozzi R, Calabrese M.   +11 more
europepmc   +1 more source